| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 67,1 k € | -29.1% | 94,6 k € | +128.5% | 41,4 k € | -48.1% | 79,8 k € | -42.6% | 139,0 k € | +2.7% | 135,3 k € | +3.2% | 131,1 k € | +28.5% | 102,0 k € | -19.3% | 126,5 k € | +34.6% | 94,0 k € | -20.6% | 118,4 k € | -7.3% | 127,7 k € | +9.8% | 116,2 k € | +19.6% | 97,2 k € | |
| EBITDA | 66,1 k € | -29.4% | 93,7 k € | +128.4% | 41,0 k € | -37.3% | 65,4 k € | -32.8% | 97,4 k € | +9.1% | 89,3 k € | +16.2% | 76,8 k € | +81.7% | 42,3 k € | -38.1% | 68,3 k € | +71.7% | 39,8 k € | -40.8% | 67,2 k € | -13.6% | 77,8 k € | +17.9% | 66,0 k € | +30.6% | 50,5 k € | |
| Operating profit | 53,7 k € | -29.5% | 76,2 k € | +187.2% | 26,5 k € | -14.4% | 31,0 k € | -50.9% | 63,1 k € | +11.3% | 56,7 k € | +38.2% | 41,0 k € | +1107.4% | -4,1 k € | -110.9% | 37,3 k € | +587.7% | 5,4 k € | -81.8% | 29,8 k € | -23.5% | 38,9 k € | +33.8% | 29,1 k € | +570.1% | 4,3 k € | |
| Profit/loss | 37,2 k € | -29.5% | 52,8 k € | +223.8% | 16,3 k € | -17.4% | 19,8 k € | -56.2% | 45,1 k € | +11.8% | 40,3 k € | +25.7% | 32,1 k € | +519.8% | -7,6 k € | -122.5% | 34,0 k € | +4153.4% | 799,3 € | -96.1% | 20,5 k € | -17.5% | 24,9 k € | +1.5% | 24,5 k € | +783.3% | -3,6 k € | |
| Equity | 186,9 k € | +23.5% | 151,4 k € | +51.0% | 100,3 k € | -3.3% | 103,7 k € | +23.5% | 84,0 k € | +42.6% | 58,9 k € | +52.7% | 38,6 k € | +20.6% | 32,0 k € | -19.3% | 39,6 k € | -0.0% | 39,6 k € | +2.1% | 38,8 k € | +87.4% | 20,7 k € | +2.4% | 20,2 k € | +11.6% | 18,1 k € | |
| Total assets | 210,1 k € | +10.3% | 190,5 k € | +36.4% | 139,7 k € | -11.0% | 157,0 k € | -2.3% | 160,7 k € | +9.9% | 146,3 k € | -10.0% | 162,5 k € | +0.2% | 162,2 k € | +28.7% | 126,0 k € | +23.1% | 102,3 k € | -17.4% | 123,9 k € | +13.1% | 109,6 k € | -17.7% | 133,1 k € | -2.5% | 136,5 k € | |
| Cash | 71,9 k € | -23.7% | 94,2 k € | +241.8% | 27,6 k € | -50.0% | 55,1 k € | -14.3% | 64,3 k € | +117.4% | 29,6 k € | -31.3% | 43,1 k € | +224.3% | 13,3 k € | -59.4% | 32,7 k € | +153.4% | 12,9 k € | -8.6% | 14,1 k € | -41.9% | 24,3 k € | -36.2% | 38,1 k € | +335.8% | 8,7 k € | |
| Debts | 23,3 k € | -40.6% | 39,1 k € | +1.9% | 38,4 k € | -21.5% | 48,9 k € | -35.1% | 75,3 k € | -13.8% | 87,4 k € | -29.5% | 124,0 k € | -4.7% | 130,1 k € | +50.7% | 86,3 k € | +37.8% | 62,7 k € | -24.4% | 82,8 k € | -6.7% | 88,8 k € | -21.4% | 112,9 k € | -4.6% | 118,4 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 1,5 | 1,5 | 1,5 | 1,5 | 1,4 | ||||||||||||||
Source: Belgian Official Gazette
Private limited company · Menen · incorporated on 21/03/1994
Private limited company profitable and well capitalised. Cash position declining (-23.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTERS BUYSE-KENIS is a Private limited company incorporated in 1994. Its main activity is: Other human health activities. Its registered office is in Menen.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.